Correlation between DQB1 genetic polymorphism and genetic susceptibility in patients diagnosed with irritable bowel syndrome with diarrhea

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 10285-10293

  Yu, F ^a   Huang, S ^b   Zhou, F ^b   Luo, Q ^b   Xie, X ^c   Zheng, C ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b University City Branch   (China)

^c Guangdong HTCM Hospital   (China)

Author keywords

Human leucocyte antigen DQB1 gene; Interleukin 10; Irritable bowel syndrome with diarrhea

Indexed keywords

HLA DQB1 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; PROTEIN ZO1; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; IL10 PROTEIN, HUMAN; TJP1 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DQB1 GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAN CHINESE; HUMAN; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SEX RATIO; ZO1 GENE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CHINA; COLON; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COLON; DIARRHEA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ BETA-CHAINS; HUMANS; INTERLEUKIN-10; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84915745638     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.December.4.23     Document Type: Article

References (21)

1. Adler SN, Jacob H, Lijovetzky G, Mulder CJ, et al. (2006). Positive coeliac serology in irritable bowel syndrome patients with normal duodenal biopsies: video capsule endoscopy findings and HLA-DQ typing may affect clinical management. J. Gastrointestin. Liver Dis. 15: 221-225.
2. Aerssens J, Camilleri M, Talloen W, Thielemans L, et al. (2008). Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 6: 194-205.
3. Arrieta MC, Bistritz L and Meddings JB (2006). Alterations in intestinal permeability. Gut 55: 1512-1520.
4. Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, et al. (2011). The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am. J. Gastroenterol. 106: 2165-2173.
5. Camilleri M, McKinzie S, Busciglio I, Low PA, et al. (2008). Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 6: 772-781.
6. Chan PK, Cheung JL, Cheung TH, Lin CK, et al. (2001). HLA-DQB1 polymorphisms and risk for cervical cancer: A case-control study in a southern Chinese population. Gynecol. Oncol. 105: 736-741.
7. Chang FY, Lu CL and Chen TS (2010). The current prevalence of irritable bowel syndrome in Asia. J. Neurogastroenterol. Motil. 16: 389-400.
8. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, et al. (2003). Interleukin 10 genotypes in irritable bowel syndrome: Evidence for an inflammatory component? Gut 52: 91-93.
9. Liu Y, Ye Z, Luo H, Sun M, et al. (2009). Inhalative formaldehyde exposure enhances aggressive behavior and disturbs monoamines in frontal cortex synaptosome of male rats. Neurosci. Lett. 464: 113-116.
10. Locke GR 3rd, Murray JA, Zinsmeister AR, Melton LJ 3rd, et al. (2004). Celiac disease serology in IBS and dyspepsia: a population-based case-control study. Mayo Clin. Proc. 79: 476-482.
11. Megiorni F and Pizzuti A (2012). HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J. Biomed. Sci. 19: 88-93.
12. Nahidi L, Leach ST, Mitchell HM, Kaakoush NO, et al. (2013). Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed. Res. Int. 2013; 909613.
13. Neagoe A, Molnar AM, Acalovschi M, Seicean A, et al. (2004). Risk factors for colorectal cancer: an epidemiologic descriptive study of a series of 333 patients. Rom. J. Gastroenterol. 13: 187-193.
14. Park DW, Lee OY, Shim SG, Jun DW, et al. (2010). The differences in prevalence and sociodemographic characteristics of irritable bowel syndrome according to Rome II and Rome III. J. Neurogastroenterol. Motil. 16: 186-193.
15. Schmulson M, Pulido-London D, Rodríguez O, Morales-Rochlin N, et al. (2012). Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am. J. Gastroenterol. 107: 747-753.
16. Schmulson M, Pulido-London D, Rodríguez O, Morales-Rochlin N, et al. (2013). IL-10 and TNF-alpha polymorphisms in subjects with irritable bowel syndrome in Mexico. Rev. Esp. Enferm. Dig. 105: 392-399.
17. Sun M, Zhou T, Zhou L, Chen Q, et al. (2012). Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAβPPα. J. Alzheimers Dis. 28: 795-808.
18. Vanderpool C, Yan F and Polk DB (2008). Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bowel Dis. 14: 1585-1596.
19. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, et al. (2012). Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am. J. Physiol. Gastrointest. Liver Physiol. 303: G1262-G1269.
20. Verdu EF, Huang X, Natividad J, Lu J, et al. (2008). Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G217-G225.
21. Wahnschaffe U, Schulzke JD, Zeitz M and Ullrich R (2007). Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 5: 844-850.